High levels of SGK1 expression have been observed in several tumors including colon cancer [32], prostate cancer [33], ovarian cancer [34], non-small cell lung cancer [35], hepatocellular carcinoma [36], glioblastoma multiforme [5], myeloma [37], and medulloblastoma [38]. Here, SGK1 is linked to prostate carcinoma.